{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T12:05:10Z","timestamp":1768046710307,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jcyt.2025.09.010","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T03:14:38Z","timestamp":1760066078000},"page":"101987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond body weight: investigating the impact of body surface area on graft CD34+ cell dosing: a single-center experience"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0651-6081","authenticated-orcid":false,"given":"Seungwon","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste","family":"Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-8276","authenticated-orcid":false,"given":"Chukwuemeka","family":"Uzoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3687-2034","authenticated-orcid":false,"given":"Matias","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Zucchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-2120","authenticated-orcid":false,"given":"Sally","family":"Campbell-Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6301-4931","authenticated-orcid":false,"given":"Zhengjia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damiano","family":"Rondelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3113-9155","authenticated-orcid":false,"given":"Nadim","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2025.09.010_bib0001","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-024-01062-2","article-title":"Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation","volume":"14","author":"Pasvolsky","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0002","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/ajh.27451","article-title":"Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: a study of the worldwide network for blood and marrow transplantation (WBMT)","volume":"99","author":"Garderet","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0003","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41408-019-0205-9","article-title":"Current status of autologous stem cell transplantation for multiple myeloma","volume":"9","author":"Al Hamed","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0004","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1158\/2767-9764.CRC-23-0185","article-title":"Clinical benefit of autologous stem cell transplantation for patients with multiple myeloma achieving undetectable minimal residual disease after induction treatment","volume":"3","author":"Liu","year":"2023","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11912-024-01537-2","article-title":"Minimal residual disease-adapted therapy in multiple myeloma: current evidence and opinions","volume":"26","author":"Meseha","year":"2024","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0006","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/blood.2024024371","article-title":"EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma","volume":"144","author":"Landgren","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0007","first-page":"2049","article-title":"Role of minimal residual disease assessment in multiple myeloma","volume":"109","author":"Szalat","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0008","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00277-020-03914-w","article-title":"Two decades of experience in a combined adult\/pediatric allogeneic hematopoietic stem cell transplantation center in Algiers","volume":"99","author":"Benakli","year":"2020","journal-title":"Algeria Ann Hematol"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/917361","article-title":"Autologous hematopoietic stem cell transplantation for multiple myeloma without cryopreservation","volume":"2012","author":"Al-Anazi","year":"2012","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41408-023-00920-9","article-title":"The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant","volume":"13","author":"Zanwar","year":"2023","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0011","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41409-023-02035-y","article-title":"Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience","volume":"58","author":"Yassine","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0012","doi-asserted-by":"crossref","first-page":"421\u00d737","DOI":"10.4252\/wjsc.v15.i5.421","article-title":"Communication between bone marrow mesenchymal stem cells and multiple myeloma cells: Impact on disease progression","volume":"15","author":"Garcia-Sanchez","year":"2023","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0013","doi-asserted-by":"crossref","first-page":"93\u00d7106","DOI":"10.1159\/000495455","article-title":"Recent advances in the diagnosis, risk stratification, and management of systemic light-chain amyloidosis","volume":"141","author":"Vaxman","year":"2019","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0014","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215148","article-title":"Inflammatory bone marrow mesenchymal stem cells in multiple myeloma: transcriptional signature and in vitro modeling","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112542","article-title":"Bone marrow mesenchymal stromal cells in multiple myeloma: their role as active contributors to myeloma progression","volume":"13","author":"Maiso","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0017","series-title":"BMI classification percentile and cut off points","author":"Weir","year":"2021"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0018","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.clml.2019.11.001","article-title":"Effects of obesity on overall survival of adults with acute myeloid leukemia","volume":"20","author":"Dhakal","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0019","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41416-023-02362-3","article-title":"Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience","volume":"129","author":"Enssle","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12929-022-00796-0","article-title":"The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy","volume":"29","author":"Assumpcao","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0021","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.bmt.1702692","article-title":"Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft","volume":"26","author":"Tarella","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0022","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/met.2023.0048","article-title":"The effect of obesity and body mass index on hematologic malignancies","volume":"21","author":"Bilgihan","year":"2023","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0023","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1182\/blood-2013-03-490334","article-title":"Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation","volume":"123","author":"Aplenc","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0024","doi-asserted-by":"crossref","first-page":"52","DOI":"10.14216\/kjco.23010","article-title":"The prognostic impact of body mass index in breast cancer according to tumor subtype","volume":"19","author":"Kim","year":"2023","journal-title":"Korean J Clin Oncol"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18278-x","article-title":"Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: a meta-analysis","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0026","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.7150\/jca.59064","article-title":"Impact of body mass index on local recurrence according to intrinsic subtype approximation in korean women with early stage invasive breast cancer receiving contemporary treatments","volume":"12","author":"Kim","year":"2021","journal-title":"J Cancer"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0027","article-title":"Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0028","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/ejh.13856","article-title":"A comparison of four leukapheresis methods to harvest an optimal dose of CD34+ cells: a single center experience","volume":"109","author":"Lin","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0029","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/jca.21941","article-title":"Hematopoietic progenitor cell counting can optimize peripheral blood stem cell apheresis process","volume":"36","author":"Rebersek","year":"2021","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bmt.1705098","article-title":"Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients","volume":"36","author":"Bochennek","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0031","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1526-0968.2002.00406.x","article-title":"Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield","volume":"6","author":"Demirer","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0032","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.htct.2023.04.006","article-title":"Outcomes of patients after mobilization failure of hematopoietic stem cells for autologous stem cell transplantation","volume":"46","author":"Santinelli-Pestana","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0033","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1200\/JCO.2000.18.6.1360","article-title":"Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy","volume":"18","author":"Siena","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0034","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.bbmt.2020.07.004","article-title":"Busulfan pharmacokinetics in adenosine deaminase-deficient severe combined immunodeficiency gene therapy","volume":"26","author":"Bradford","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15313","article-title":"Effects of CD34(+) cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation","volume":"38","author":"Oyama","year":"2024","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0036","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bbmt.2017.03.036","article-title":"Cryopreserved CD34(+) cell dose, but not total nucleated cell dose, influences hematopoietic recovery and extensive chronic graft-versus-host disease after single-unit cord blood transplantation in adult patients","volume":"23","author":"Konuma","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0037","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jca.21914","article-title":"Race\/ethnicity and underlying disease influences hematopoietic stem\/progenitor cell mobilization response: a single center experience","volume":"36","author":"Uzoka","year":"2021","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0038","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.metabol.2005.11.004","article-title":"Body surface area in normal-weight, overweight, and obese adults. A comparison study","volume":"55","author":"Verbraecken","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0039","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0021-9681(72)90027-6","article-title":"Indices of relative weight and obesity","volume":"25","author":"Keys","year":"1972","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.bmt.1700897","article-title":"Factors influencing platelet recovery after blood cell transplantation in multiple myeloma","volume":"20","author":"Gertz","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0041","first-page":"57","article-title":"A phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies","volume":"6","author":"Pinguet","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101162","article-title":"Optimizing high dose melphalan","volume":"64","author":"Shah","year":"2024","journal-title":"Blood Rev"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0043","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.hemonc.2019.08.003","article-title":"Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients","volume":"13","author":"Lutfi","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2025.09.010_bib0044","doi-asserted-by":"crossref","first-page":"36.e1","DOI":"10.1016\/j.jtct.2022.10.017","article-title":"Correlation of engraftment and time from melphalan administration to stem cell infusion","volume":"29","author":"Shuman","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jcyt.2025.09.010_bib0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bmt.1704826","article-title":"Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis","volume":"35","author":"Oran","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2025.09.010_bib0046","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.bmt.1700897","article-title":"Factors influencing platelet recovery after blood cell transplantation in multiple myeloma","volume":"20","author":"Gertz","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2025.09.010_bib0047","first-page":"871","article-title":"Role of CD34+ cells in engraftment after high-dose melphalan in multiple myeloma patients given peripheral blood stem cell rescue","volume":"18","author":"Millar","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20123111","article-title":"Effects of estrogens on platelets and megakaryocytes","volume":"20","author":"Dupuis","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0049","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11892-018-1031-3","article-title":"Gender and Sex Differences in Adipose Tissue","volume":"18","author":"Chang","year":"2018","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0050","first-page":"301","article-title":"Metabolically active components of fat free mass (FFM) and resting energy expenditure (REE) in humans","volume":"56","author":"Muller","year":"2003","journal-title":"Forum Nutr"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0051","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0884533612457949","article-title":"Importance of lean body mass in the oncologic patient","volume":"27","author":"Tsai","year":"2012","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0052","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/eurheartj\/ehn213","article-title":"Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction","volume":"29","author":"Muller-Ehmsen","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0053","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3324\/haematol.2021.280189","article-title":"Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies","volume":"107","author":"Dos Santos","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2025.09.010_bib0054","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/jcsm.12570","article-title":"Abnormal body composition is a predictor of adverse outcomes after autologous haematopoietic cell transplantation","volume":"11","author":"Armenian","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"10.1016\/j.jcyt.2025.09.010_bib0055","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bmt.1702643","article-title":"Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)","volume":"26","author":"Gertz","year":"2000","journal-title":"Bone Marrow Transplant"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925008473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925008473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:50:36Z","timestamp":1767963036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324925008473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1465324925008473"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.09.010","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond body weight: investigating the impact of body surface area on graft CD34+ cell dosing: a single-center experience","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101987"}}